
# Enum: ResponseSystemEnum




URI: [https://w3id.org/pcdc/model/ResponseSystemEnum](https://w3id.org/pcdc/model/ResponseSystemEnum)


## Other properties

|  |  |  |
| --- | --- | --- |

## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| iRANO | Response assessment criteria for the evaluation of patients undergoing immunotherapy for the treatment of malignant glioma. These recommendations integrate guidance for the determination and confirmation of tumor progression based on the response assessment in neuro-oncology (RANO) working group and the immune-related response criteria (irRC). | ncit:C131131 |  |
| RANO | An update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM). | ncit:C114879 |  |
| Unknown | Reported as unknown by the data contributor. | ncit:C17998 |  |
| Not Reported | Not provided or available. | ncit:C43234 |  |
| RECIST | Standard parameters to be used when documenting response of solid tumors to treatment; a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable"), or worsen ("progression") during treatments. (from www.recist.com) | ncit:C49164 |  |
| WHO | A United Nations agency established to coordinate international health activities and to help governments improve health services. | ncit:C75419 |  |
| Choi | A composite set of criteria developed by Choi et al. using imaging techniques in the evaluation of gastrointestinal stromal tumors response to imatinib mesylate treatment. These criteria integrate changes in tumor size and tumor density. | ncit:C122394 |  |
| mRECIST | Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. (Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004 Feb;15(2):257-60.) | ncit:C126031 |  |
| PERCIST | From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. (Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009 May;50 Suppl 1:122S-50S.) | ncit:C126039 |  |

